Background Systematic reviews showed that systemic postnatal corticosteroids reduce the
risk of bronchopulmonary dysplasia (BPD) in preterm infants. However, corticosteroids have …

Despite modern perinatal intensive care techniques, chronic lung disease remains a
problem in preterm-born infants. The most commonly and almost exclusively prescribed …

Background Systemic corticosteroids as the frontline treatment of respiratory distress
syndrome (RDS) in preterm infants are associated with adverse effects on growth and …

Objective To determine the comparative efficacy and safety of corticosteroids in the
prevention of bronchopulmonary dysplasia (BPD) in preterm infants. Study design We …

Background: A full consensus has not been reached about the hemodynamic efficacy of
hydrocortisone administration in hypotensive and vasopressor-dependent preterm …

Importance The safety of postnatal corticosteroids used for prevention of bronchopulmonary
dysplasia (BPD) in preterm neonates is a controversial matter, and a risk-benefit balance …

OBJECTIVE. Postnatal steroid use decreases lung inflammation but increases impairment.
We hypothesized that increased dose is associated with increased neurodevelopmental …

Objective. To assess the effectiveness of a “stress dose” of hydrocortisone for rescue
treatment of refractory hypotension and adrenocortical insufficiency of prematurity in very …

Postnatal corticosteroids have been used for prevention and treatment of neonatal chronic
lung disease (CLD)(also know as bronchopulmonary dysplasia), a significant cause of …

Background Recent reports have raised concerns that postnatal steroids may cause neuro-
developmental impairment in preterm infants. This systematic review was performed with the …